Search

everythinglearnresearchcommunity

for

Search:↓

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

The nanoparticles improved minoxidil's skin absorption, making them promising for skin treatments.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Noggin promotes skin tumors by activating Wnt and Shh pathways.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Blocking TGFβ can help treat fibrotic skin conditions by promoting fat cell formation.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Minoxidil helps prevent hair loss from chemotherapy in rats.

Apigenin, found in plants and vegetables, has many health benefits, including anti-inflammatory, antioxidant, and anticancer effects.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Peficitinib can turn human fibroblasts into cells that help grow hair.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Minoxidil may help treat hair loss by reducing inflammation-related gene activity in skin cells.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Niosomes and ethosomes can effectively carry the drug spironolactone, potentially improving treatment for hair loss and reducing side effects.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

The compound 4c effectively inhibits the enzyme linked to hair loss.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Normal human melanocytes can avoid cell death through multiple pathways.

EGFR inhibitors for lung cancer can cause severe skin issues.